261780 — CHA Vaccine Research Institute Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩130bn
- KR₩95bn
- KR₩294m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2,980 | -6,240 | -18,420 | -6,715 | -1,749 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 198 | 2,447 | 13,016 | 996 | -4,198 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -345 | -299 | 419 | 114 | 121 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3,093 | -3,954 | -4,740 | -5,189 | -5,293 |
Capital Expenditures | -124 | -53.5 | -683 | -447 | -291 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6,161 | -6,818 | -46,780 | 4,184 | 22,221 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -6,285 | -6,872 | -47,463 | 3,736 | 21,930 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 12,035 | 19,991 | 44,320 | -116 | -13,117 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,657 | 9,165 | -7,883 | -1,568 | 3,520 |